SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-154190
Filing Date
2023-05-25
Accepted
2023-05-25 16:02:00
Documents
12
Period of Report
2023-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d509829d8k.htm   iXBRL 8-K 27777
  Complete submission text file 0001193125-23-154190.txt   146535

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA agio-20230522.xsd EX-101.SCH 2833
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20230522_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20230522_pre.xml EX-101.PRE 10801
6 EXTRACTED XBRL INSTANCE DOCUMENT d509829d8k_htm.xml XML 3230
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 23960360
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences